[Caring for perilesional skin or skin having a lesion risk].
In order to increase the clinical and scientific evidence of the Hyperoxygenated Fatty Acids (HFA) in emulsion preparation for skin care, this study considers to evaluate prospectively how it influences in the state of the periwound skin (when there are active lesions) or in which it presents a high risk of lesion production.
Segovia
Gómez T
GT
Unidad Interdisciplinar de úlceras por Presión y Heridas Crónicas del Hospital G.U. Puerta de Hierro de Madrid.
Javares
Curto T
CT
Barahona
M
M
Verdú
Soriano J
SJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D003627:Data Interpretation, Statistical; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004655:Emulsions; D005227:Fatty Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D012307:Risk Factors; D012867:Skin / Q000187:drug effects* / Q000473:pathology*; D017592:Skin Care / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome
D003879:Dermatologic Agents; D004655:Emulsions; D005227:Fatty Acids; C479536:Mepentol; D009824:Ointments; D010936:Plant Extracts